date,title,source
Nov-05-18,Arcturus Therapeutics Hosts Ribbon Cutting Ceremony for its Research and Development Facility,GlobeNewswire
Nov-07-18,Arcturus Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results,GlobeNewswire
Dec-03-18,Arcturus Therapeutics to Host a Key Opinion Leader Call on Ornithine Transcarbamylase (OTC) Deficiency on December 11,GlobeNewswire
Dec-18-18,Activists Having Busier-Than-Ever 2018 as Icahn Returns to Fray,Bloomberg
Dec-21-18,Do Insiders Own Lots Of Shares In Arcturus Therapeutics Ltd. (NASDAQ:ARCT)?,Simply Wall St.
Dec-31-18,Penny Stocks to Buy Using Technical Analysis for January 2019,Investopedia
Jan-02-19,Arcturus Therapeutics to Develop ARCT-810 for Treatment of Ornithine Transcarbamylase (OTC) Deficiency,GlobeNewswire
Jan-03-19,Arcturus Therapeutics Appoints Andrew Sassine as Chief Financial Officer,GlobeNewswire
